SCA8_ATXN8OS

Gene
ATXN8OS
Disease
SCA8
Inheritance
AD
Classification
Definitive
Total Score
11.5
Publications Reviewed
3
Publication Span
22.61 years
Last Updated
08/12/2025
Curator(s)
Macayla Weiner, Laurel Hiatt, Harriet Dashnow

Description

SCA8 is associated with a dominantly inherited CTG•CAG repeat expansion at the ATXN8OS/ATXN8 locus. Evidence includes expanded alleles in SCA8 families with reduced penetrance, enrichment of CCG•CGG interruptions in higher-penetrance families, bidirectional transcription producing noncoding CUG-containing ATXN8OS RNA and CAG/polyglutamine products, and cell/model data supporting RNA and protein gain-of-function mechanisms.

Genetic evidence

Total: 6

Singular EvidenceProbandsPMID:346327106Large SCA8 cohort of 77 families including 199 expansion carriers (111 affected, 88 asymptomatic); 10 families showed autosomal-dominant inheritance and CCG•CGG interruptions were enriched in families with multiple affected individuals.
1 rows

Experimental evidence

Total: 5.5

FunctionBiochemical functionPMID:101923870.5ATXN8OS is transcribed through the SCA8 CTG repeat as a processed, untranslated CUG-containing RNA; brain/cerebellar expression supports a locus-specific RNA function.
FunctionRegulatory impactPMID:101923870.5Supports ATXN8OS transcription and possible antisense regulatory biology.
FunctionRegulatory impactPMID:101923871.5Strand-specific RT-PCR/RACE showed the CTG repeat is in a spliced, polyadenylated ATXN8OS transcript expressed in brain and overlapping an opposite-strand transcript, supporting locus-specific regulatory impact.
ModelsNon-human model organismPMID:168045412A transgenic SCA8 mouse model was created with the full-length human SCA8 (CTG)116 expansion transcribed under its endogenous promoter. The mice developed a progressive neurological phenotype and reduced cerebellar-cortical inhibition.
ModelsCell culturePMID:346327101Patient-derived repeat constructs in T98/HEK293T cells showed CCG•CGG interruptions increased cell toxicity, p-eIF2α activation, and polyAla/polySer RAN protein levels independent of RNA abundance.
5 rows

Note: Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.